BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Huang L, Xu H, Wu T, Li G. Hedyotis diffusa Willd. Suppresses Hepatocellular Carcinoma via Downregulating AKT/mTOR Pathways. Evid Based Complement Alternat Med 2021;2021:5210152. [PMID: 34527062 DOI: 10.1155/2021/5210152] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Wu H, Zhang L, Wang C, Li F, Qi L, Xiao L, Zhang M, Zhang H, Zhang G, Qin Y. Network Pharmacology Analysis and Experimental Verification on Antiangiogenesis Mechanism of Hedyotis diffusa Willd in Liver Cancer. Evid Based Complement Alternat Med 2023;2023:1416841. [PMID: 36647454 DOI: 10.1155/2023/1416841] [Reference Citation Analysis]
2 Chen H, Shang X, Yuan H, Niu Q, Chen J, Luo S, Li W, Li X. Total flavonoids of Oldenlandia diffusa (Willd.) Roxb. suppresses the growth of hepatocellular carcinoma through endoplasmic reticulum stress-mediated autophagy and apoptosis. Front Pharmacol 2022;13. [DOI: 10.3389/fphar.2022.1019670] [Reference Citation Analysis]
3 Wu Z, Yin B, You F. Molecular Mechanism of Anti-Colorectal Cancer Effect of Hedyotis diffusa Willd and Its Extracts. Front Pharmacol 2022;13:820474. [PMID: 35721163 DOI: 10.3389/fphar.2022.820474] [Reference Citation Analysis]
4 Sheng D, Zhao B, Zhu W, Wang T, Peng Y. Scutellaria barbata D.Don (SBD) extracts suppressed tumor growth, metastasis and angiogenesis in Prostate cancer via PI3K/Akt pathway. BMC Complement Med Ther 2022;22:120. [PMID: 35505400 DOI: 10.1186/s12906-022-03587-0] [Reference Citation Analysis]